The cancers bearing Apc-truncating mutations all showed aberrantly elevated levels of nuclear β-catenin (Fig. 6C), suggesting that loss of Apc function and disruption of the canonical Wnt/β-catenin pathway can play a role in the progression to carcinoma in this model. The gene discussed is APC; the disease is cancer.